ANTERIDES LTD
Opportunity 73/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (76/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · FRS 102Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2026-04-30 | 2025-04-30 |
|---|---|---|
| Total assets | £-142.0k | £-132.8k |
| Current assets | £1.7k | £2.7k |
| Cash | £624 | £877 |
| Debtors | £1.0k | £1.9k |
| Net assets | £-142.0k | £-132.8k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
2 signals detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 accounts
- • 1 accounts
- • 1 accounts
- • 1 confirmation-statement
Corporate timeline (18 events)Click to expand
- 2026-07-02📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2025-06-13📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-08-12📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-07-31📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2022-06-20📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2022-05-27📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2021-06-07📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2020-06-01📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2020-02-19📄change-person-secretary-company-with-change-dateofficers · CH03
- 2020-02-18📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2019-06-14📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2018-07-31📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2017-08-03📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2016-09-08📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2016-08-11📄change-person-director-company-with-change-dateofficers · CH01
- 2015-04-08🏢Company incorporatedAs ANTERIDES LTD
- 2015-04-08➕LOKWAN, Steven appointedsecretary
- 2015-04-08➕LOKWAN, Steven John Apoug, Dr appointeddirector
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +No director turnover: Company is 11 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanShareholders & ownership
1 active beneficial owner| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr Steven John Apoug Lokwan Individual · British · DOB 04/1975 · age 51 | — | — | sig. influencesignificant influence | 06/04/2016 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · EC postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| ANCHOR POINT CARE SERVICES LTD→ 16603091 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ANDROMEDA FOUNDATION→ 14134003 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| ANNUR MEDICAL LTD→ 15413369 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| APEX CBCT LTD→ 15767722 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| APOTEKA LIMITED→ 16844936 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| APRP GROUP LTD→ 16602418 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AQLIOS MED TECH LTD→ 16837135 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AQUABUMP LTD→ 17008822 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| ARBOR VITAMINS LTD→ 14171597 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| ARDERN HOLDINGS LTD→ 14459398 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| ARECONSULTANCY LTD→ 13640136 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| AREEN LTD→ 07968176 · est 2012 · no financials extracted | — | — | — | — | 14y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 0 resigned)
Click a director name to see their full track record across all companies.